Back to Journals » Cancer Management and Research » Volume 14
Original Research
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,222 | Dovepress* | 3,863+ | 92 | 3,955 | |
PubMed Central* | 359 | 147 | 506 | ||
Totals | 4,222 | 239 | 4,461 | ||
*Since 16 November 2022 |
View citations on PubMed Central and Google Scholar